Exponent Inc. (EXPO) Set to Announce Earnings on Wednesday
Exponent Inc. (NASDAQ:EXPO) is set to issue its quarterly earnings data after the market closes on Wednesday, October 19th. Analysts expect the company to announce earnings of $0.34 per share for the quarter.
Exponent (NASDAQ:EXPO) last announced its earnings results on Tuesday, July 19th. The company reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by $0.05. The business had revenue of $77.30 million for the quarter, compared to analysts’ expectations of $80.46 million. Exponent had a net margin of 15.13% and a return on equity of 16.02%. On average, analysts expect Exponent to post $1.47 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.
Shares of Exponent Inc. (NASDAQ:EXPO) opened at 49.25 on Tuesday. The stock has a market capitalization of $1.28 billion, a PE ratio of 28.14 and a beta of 0.85. Exponent Inc. has a 12 month low of $44.82 and a 12 month high of $59.71. The stock’s 50 day moving average is $50.04 and its 200 day moving average is $51.90.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/exponent-inc-expo-set-to-announce-earnings-on-wednesday.html
The company also recently declared a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Friday, September 2nd were given a dividend of $0.18 per share. The ex-dividend date was Wednesday, August 31st. This represents a $0.72 annualized dividend and a yield of 1.46%. Exponent’s dividend payout ratio is presently 41.62%.
In related news, insider Paul Boehm sold 5,000 shares of the firm’s stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $52.18, for a total transaction of $260,900.00. Following the sale, the insider now owns 24,045 shares in the company, valued at $1,254,668.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 3.50% of the company’s stock.
Several hedge funds have recently made changes to their positions in the stock. Riverhead Capital Management LLC raised its stake in shares of Exponent by 1,044.8% in the second quarter. Riverhead Capital Management LLC now owns 66,968 shares of the company’s stock valued at $6,278,000 after buying an additional 61,118 shares during the period. WBI Investments Inc. bought a new stake in shares of Exponent during the second quarter valued at about $2,294,000. Atlanta Capital Management Co. L L C raised its stake in shares of Exponent by 4.4% in the second quarter. Atlanta Capital Management Co. L L C now owns 920,771 shares of the company’s stock valued at $53,782,000 after buying an additional 38,882 shares during the period. BlackRock Fund Advisors raised its stake in shares of Exponent by 2.4% in the second quarter. BlackRock Fund Advisors now owns 1,631,643 shares of the company’s stock valued at $95,304,000 after buying an additional 38,240 shares during the period. Finally, Parametric Portfolio Associates LLC raised its stake in shares of Exponent by 11.1% in the second quarter. Parametric Portfolio Associates LLC now owns 76,511 shares of the company’s stock valued at $4,469,000 after buying an additional 7,661 shares during the period. Institutional investors and hedge funds own 91.57% of the company’s stock.
EXPO has been the topic of several analyst reports. Cantor Fitzgerald initiated coverage on shares of Exponent in a research report on Friday, August 26th. They set a “buy” rating and a $57.00 price target on the stock. Zacks Investment Research upgraded shares of Exponent from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 20th. Finally, Avondale Partners initiated coverage on shares of Exponent in a research report on Thursday, July 7th. They set a “market perform” rating and a $60.00 price target on the stock.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.